Literature DB >> 23378184

Simultaneous occurrence of gastric antral vascular ectasia and protein-losing enteropathy in chronic graft-versus-host disease.

Masahiro Hirayama1, Eiichi Azuma, Atsuko Nakazawa, Shotaro Iwamoto, Hidemi Toyoda, Yoshihiro Komada.   

Abstract

Gastric antral vascular ectasia (GAVE) leading to upper gastrointestinal bleeding is a heterogeneous disorder that is not commonly recognized in hematopoietic stem cell transplantation (HSCT). Protein-losing enteropathy (PLE) is noted as another gastrointestinal complication in the context of chronic graft-versus-host disease (GVHD) after HSCT. The possibility of a relationship between these two distinct gastrointestinal disorders, however, remains obscure. A 6-year-old boy with acute myelogenous leukemia developed severe hematemesis 4 months after myeloablative HSCT from a human leukocyte antigen-matched sibling donor. The diagnosis of GAVE was made by upper endoscopy and histological examination. The patient simultaneously developed frequent diarrhea and significant hypoproteinemia, consistent with a diagnosis of PLE. This co-occurrence of GAVE and PLE against a background of chronic GVHD was successfully treated with cyclosporin A and prednisolone. To our knowledge, this is the first report of GAVE concurrent with PLE following HSCT. The possible association of GAVE and PLE in chronic GVHD is discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23378184     DOI: 10.1007/s12185-013-1279-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  38 in total

Review 1.  Gastric antral vascular ectasia (GAVE): an update on clinical presentation, pathophysiology and treatment.

Authors:  Christian P Selinger; Yeng S Ang
Journal:  Digestion       Date:  2008-04-04       Impact factor: 3.216

2.  Gastric antral vascular ectasia (the watermelon stomach): a brief case report.

Authors:  S Lanzafame; A Torrisi; L Nesi; V Russo; G Cimino; A Rumeo; C Emmanuele
Journal:  Hepatogastroenterology       Date:  1998 Mar-Apr

Review 3.  Cutaneous graft-versus-host disease.

Authors:  S Aractingi; O Chosidow
Journal:  Arch Dermatol       Date:  1998-05

4.  Efficacy of neodymium:YAG laser therapy for gastric antral vascular ectasia (GAVE) following hematopoietic cell transplant.

Authors:  R R E Selinger; G B McDonald; D M Hockenbery; G Steinbach; M B Kimmey
Journal:  Bone Marrow Transplant       Date:  2006-01       Impact factor: 5.483

5.  Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study.

Authors:  A Tran; J P Villeneuve; M Bilodeau; B Willems; D Marleau; D Fenyves; R Parent; G Pomier-Layrargues
Journal:  Am J Gastroenterol       Date:  1999-10       Impact factor: 10.864

6.  Gastric antral vascular ectasia in 2-yr-old girl undergoing unrelated cord blood stem cell transplantation.

Authors:  Yuki Kuroiwa; Nobuhiro Suzuki; Nobuo Mizue; Tsukasa Hori; Takao Endo; Yukinari Yoshida; Hiroyuki Tsutsumi
Journal:  Pediatr Transplant       Date:  2005-12

7.  Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation.

Authors:  Eric M Ward; Massimo Raimondo; Barry G Rosser; Michael B Wallace; Rolland D Dickson
Journal:  J Clin Gastroenterol       Date:  2004 Nov-Dec       Impact factor: 3.062

8.  Gastric antral vascular ectasia successfully treated by endoscopic electrocoagulation.

Authors:  M Yamada; D Nishimura; H Hoshino; N Katada; H Sano; K Kato
Journal:  J Gastroenterol       Date:  1998-08       Impact factor: 7.527

9.  Serum cholesterol in idiopathic and lupus-related protein-losing enteropathy.

Authors:  Y G Kim; C-K Lee; J-S Byeon; S-J Myung; J S Oh; S-S Nah; H-B Moon; B Yoo
Journal:  Lupus       Date:  2008-06       Impact factor: 2.911

10.  Dramatic improvement of watermelon stomach with alpha-interferon.

Authors:  P Disdier; N Schleinitz; M Perreard; D Monges; L Swiader; A Gérolami; J R Harlé; P J Weiller
Journal:  Am J Gastroenterol       Date:  1995-06       Impact factor: 10.864

View more
  1 in total

1.  HSCT-GAVE as a Manifestation of Chronic Graft versus Host Disease: A Case Report and Review of the Existing Literature.

Authors:  Michael J Grant; Mitchell E Horwitz
Journal:  Case Rep Transplant       Date:  2018-03-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.